Abstract | OBJECTIVE: STUDY DESIGN: Nineteen thoracotomy patients from our database were identified. Thoracotomy was performed for therapeutic reasons in 11 patients and to clarify the diagnosis in eight. RESULTS: Among the 11 patients with chemotherapy-resistant pulmonary tumors, 10 of 11 (90.9%) achieved remission with thoracotomy. Thoracotomy was more likely to be done to clarify diagnosis before 1980 (83%) than after 1980 (23%) (p = 0.04), when it became more likely to be done for therapeutic indications. Ten patients had solitary lung lesions and 9 had multiple lesions. Four patients died (21%), with an average survival after thoracotomy of 149 days; patients had bilateral or multiple lung lesions, median preoperative hCG was 58,000 mIU/mL and all were stage IV. Survivors had lower stage disease, were more likely to have solitary lesions and had lower preoperative hCG levels. CONCLUSION: There have been several temporal changes in the indications for thoracotomy for GTN. In general, the optimal patient to achieve remission with thoracotomy will have stage III disease, a preoperative hCG of < 1,500 mIU/mL, and a solitary lung nodule resistant to chemotherapy. Likelihood of remission after thoracotomy is high in properly selected patients.
|
Authors | Evelyn L Fleming, Leslie Garrett, Whitfield B Growdon, Michael Callahan, Nicole Nevadunsky, Sue Ghosh, Donald P Goldstein, Ross S Berkowitz |
Journal | The Journal of reproductive medicine
(J Reprod Med)
Vol. 53
Issue 7
Pg. 493-8
(Jul 2008)
ISSN: 0024-7758 [Print] United States |
PMID | 18720924
(Publication Type: Journal Article)
|
Topics |
- Adult
- Choriocarcinoma
(secondary, surgery)
- Female
- Gestational Trophoblastic Disease
(surgery)
- Humans
- Lung Neoplasms
(secondary, surgery)
- Pregnancy
- Thoracotomy
- Uterine Neoplasms
(pathology)
- Young Adult
|